tiprankstipranks
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market
AVIR
Atea Pharmaceuticals
RESEARCH TOOLSreports
Want to see AVIR full AI Analyst Report?

Atea Pharmaceuticals (AVIR) Income Statement

243 Followers

Atea Pharmaceuticals Income Statement

Last quarter (Q4 2025), Atea Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Atea Pharmaceuticals's net income was $-44.87M. See Atea Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 351.37M
Gross Profit
$ -416.00K$ -83.37M$ -70.09M$ -62.39M$ 184.16M
Operating Expenses
$ 180.89M$ 109.58M$ 94.07M$ 68.26M$ 45.78M
Depreciation and Amortization
$ 416.00K$ 416.00K$ 416.00K$ 260.00K$ 29.00K
EBITDA
$ -180.89M$ -131.80M$ -119.59M$ -110.84M$ 138.41M
Operating Income
$ -180.89M$ -192.95M$ -164.16M$ -130.65M$ 138.38M
Other Income/Expenses
$ 16.38M$ 25.49M$ 29.22M$ 11.15M$ 213.00K
Pretax Income
$ -164.51M$ -167.46M$ -134.94M$ -119.50M$ 138.59M
Net Income
$ -158.35M$ -168.38M$ -135.96M$ -115.91M$ 121.19M
Per Share Metrics
Basic EPS
$ -1.94$ -2.00$ -1.63$ -1.39$ 1.46
Diluted EPS
$ -1.94$ -2.00$ -1.63$ -1.39$ 1.37
Weighted Average Shares Outstanding
 81.50M 84.26M 83.39M 83.25M 82.82M
Weighted Average Shares Outstanding (Diluted)
 81.50M 84.26M 83.39M 83.25M 88.25M
Currency in USD

Atea Pharmaceuticals Earnings and Revenue History